These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36484251)

  • 1. Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment.
    Kandzari DE; Weber MA; Poulos C; Coulter J; Cohen SA; DeBruin V; Jones D; Pathak A
    Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e008997. PubMed ID: 36484251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment.
    Kario K; Kagitani H; Hayashi S; Hanamura S; Ozawa K; Kanegae H
    Hypertens Res; 2022 Feb; 45(2):232-240. PubMed ID: 34657136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
    Mahfoud F; Renkin J; Sievert H; Bertog S; Ewen S; Böhm M; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Parise H; Haratani N; Pathak A; Persu A
    JACC Cardiovasc Interv; 2020 Feb; 13(4):471-484. PubMed ID: 32081241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension.
    Schmieder RE; Kandzari DE; Wang TD; Lee YH; Lazarus G; Pathak A
    J Hypertens; 2021 Jan; 39(1):162-168. PubMed ID: 32773653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preference for therapies in hypertension: a cross-sectional survey of German patients.
    Schmieder RE; Högerl K; Jung S; Bramlage P; Veelken R; Ott C
    Clin Res Cardiol; 2019 Dec; 108(12):1331-1342. PubMed ID: 30941492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
    Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Denervation for Hypertension: A Systematic Review and Meta-Analysis of Randomized, Blinded, Placebo-Controlled Trials.
    Ahmad Y; Francis DP; Bhatt DL; Howard JP
    JACC Cardiovasc Interv; 2021 Dec; 14(23):2614-2624. PubMed ID: 34743900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.
    Hering D; Nikoleishvili D; Imedadze A; Dughashvili G; Klimiashvili Z; Bekaia E; Shengelia T; Kobalava M; Goguadze O; Emukhvari T; Druker V; Sackner-Bernstein J; Weber MA
    Hypertension; 2022 Dec; 79(12):2787-2795. PubMed ID: 36254733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
    Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
    Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert consensus: renal denervation for the treatment of arterial hypertension.
    Pathak A; Girerd X; Azizi M; Benamer H; Halimi JM; Lantelme P; Lefèvre T; Sapoval M; ; ; ;
    Arch Cardiovasc Dis; 2012; 105(6-7):386-93. PubMed ID: 22977923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR; Gaehwiler R; Jaguszewski M; Sudano I; Osipova J; Schoenenberger-Berzins R; Erne P; Lüscher TF; Templin C
    Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
    Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
    Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.